Hemicraniectomy for malignant middle cerebral artery syndrome: A review of functional outcomes in two high-volume stroke centers
Journal article
Pandhi, Abhi, Tsivgoulis, Georgios, Goyal, Nitin, Ishfaq, Muhammad Fawad, Male, Shailesh, Boviatsis, Efstathios, Chang, Jason J., Zand, Ramin, Voumvourakis, Konstantinos, Elijovich, Lucas, Alexandrov, Anne W., Malkoff, Marc D., Hoit, Daniel A., Arthur, Adam S. and Alexandrov, Andrei V.. (2018). Hemicraniectomy for malignant middle cerebral artery syndrome: A review of functional outcomes in two high-volume stroke centers. Journal of Stroke and Cerebrovascular Diseases. 27(9), pp. 2405 - 2410. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.04.031
Authors | Pandhi, Abhi, Tsivgoulis, Georgios, Goyal, Nitin, Ishfaq, Muhammad Fawad, Male, Shailesh, Boviatsis, Efstathios, Chang, Jason J., Zand, Ramin, Voumvourakis, Konstantinos, Elijovich, Lucas, Alexandrov, Anne W., Malkoff, Marc D., Hoit, Daniel A., Arthur, Adam S. and Alexandrov, Andrei V. |
---|---|
Abstract | Background and Purpose: Despite recent landmark randomized controlled trials showing significant benefits for hemicraniectomy (HCT) compared with medical therapy (MT) in patients with malignant middle cerebral artery infarction (MMCAI), HCT rates have not substantially increased in the United States. We sought to evaluate early outcomes in patients with MMCAI who were treated with HCT (cases) in comparison to patients treated with MT due to the perception of procedural futility by families (controls). Methods: We retrospectively evaluated consecutive patients with acute MMCAI treated in 2 tertiary care centers during a 7-year period. Pretreatment National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) at 3 months were documented. Functional independence (FI) and survival without severe disability (SWSD) were defined as mRS of 0-2 and 0-4, respectively. Results: A total of 66 patients (37 cases and 29 controls) fulfilled the study inclusion criteria (mean age 59 ± 15 years, 52% men, median admission NIHSS score: 19 points [interquartile range {IQR}: 16-22]). Cases were younger (51 ± 11 versus 68 ± 13 years; P < .001) and tended to have lower median admission NIHSS than controls (18 [IQR:16-20] versus 20 [IQR:18-23]; P = .072). The rates of FI and SWSD at 3 months were higher in cases than controls (16% versus 0% [P = .031] and 62% versus 0% [P < .001]), while 3-month mortality was lower (24% versus 77%; P < .001). Multivariable Cox regression analyses adjusting for potential confounders identified HCT as the most important predictor of lower risk of 3-month mortality (hazard ratio: .02, 95% confidence interval: .01-0.10; P < .001). Conclusions: HCT is a critical and effective therapy for patients with MMCAI but cannot provide a guarantee of functional recovery. |
Keywords | malignant ischemic stroke; large vessel occlusion; hemicraniectomy; functional independence; survival without severe disability; mortality |
Year | 2018 |
Journal | Journal of Stroke and Cerebrovascular Diseases |
Journal citation | 27 (9), pp. 2405 - 2410 |
Publisher | Elsevier - WB Saunders |
ISSN | 1052-3057 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.04.031 |
Scopus EID | 2-s2.0-85047217080 |
Page range | 2405 - 2410 |
Publisher's version | File Access Level Controlled |
Place of publication | United States of America |
https://acuresearchbank.acu.edu.au/item/874qq/hemicraniectomy-for-malignant-middle-cerebral-artery-syndrome-a-review-of-functional-outcomes-in-two-high-volume-stroke-centers
Restricted files
Publisher's version
92
total views0
total downloads1
views this month0
downloads this month